ALFA Finder| Revenue growth | 23% growth in FY26, targeting ₹300cr in FY27. |
|---|---|
| Margins | PAT margin improved from 6% to 8.5%; targeting 11-12%. |
| Demand visibility | Strong data-led demand from existing D2C customer base. |
| Management confidence | High; confident in scaling to 1000 beds eventually. |
Growth
FY26 Revenue grew 23% to ₹200cr+; EBITDA rose 73%, PAT up 74% to ₹17cr.
Outlook
Revenue targets of ₹300cr (FY27) and ₹500cr (FY28). Scaling to 300 hospital beds by end of FY27.
Risks
High receivable days in hospital segment (30-60 days); pending RBI approval for US subsidiary equity subscription.
Earnings Call filed with NSE, NSE: SATKARTAR. Summary written with AI assistance from the document.
Sat Kartar Life Ltd: key numbers
- Share price
- ₹170.90
- Market cap
- ₹269.9 Cr
- Revenue (annual)
- ₹200.7 Cr
- Net profit (annual)
- ₹17.10 Cr
- P/E (TTM)
- 15.8×Sector 43.8×
- Promoter holding
- 63.49%
- FII holding
- 0.77%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sat Kartar Life Ltd
All →Sat Kartar Life Capacity Expansion: ₹1.25 Cr Investment
Sat Kartar Life proposes a 30-bed Ayurveda hospital in Jaipur at an estimated ₹1.25 Crore investment. The facility is expected to be operational by March 2027.
- Value
- ₹1.25 Cr
- Ayurveda hospital beds
- 30 beds
Sat Kartar Life Convertible Warrants
Sat Kartar Life received NSE in-principle approval to list 5,50,000 equity shares from warrant conversion. Approval is subject to listing application and allottee undertakings.
Sat Kartar Life Capacity Expansion: ₹1 Cr Investment
Sat Kartar Life proposes a 25-bed Ayurveda hospital-cum-therapy centre in Lucknow at ₹1 Crore investment. Expected operational by February 2027 as part of its healthcare network expansion.
- Value
- ₹1.00 Cr
- Execution
- Expected operational by February 2027
- hospital beds
- 25 beds
Sat Kartar Life Earnings Call Transcript: Key Takeaways
Sat Kartar Life is pivoting from pure Ayurveda products to an integrated healthcare model, showing strong revenue growth but scaling back prior top-line guidance to prioritize margins.
- Call
- Guides 32% growth
Sat Kartar Life H1 FY27 Results: Net Profit ₹9.2 Cr, Up 26.0% YoY
Sat Kartar Life Ltd reported revenue from operations of ₹113.9 Cr (+26.4% YoY) and net profit of ₹9.2 Cr (+26.0% YoY) for H1 FY27.
- Key figure
- Net profit ₹9.2 Cr · +26.0% YoY
Sat Kartar Life Investor Presentation: Key Takeaways
H1 FY27 deck discloses no revenue, PAT or EBITDA figures. Balance sheet is debt-free with ₹18.7 Cr net cash. Growth is hospital-led: 30-bed Delhi unit at breakeven, 300 beds targeted by FY27-end.